🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

270 notícias encontradas para "clínica"
New clinical data advances stem cell-based cell therapy for Parkinson's disease
New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the
Long-term stroke data reveal stem cell therapy's safety, biological activity over years
Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.
New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant s
New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.
Foto: Negative Space / Pexels
Data highlight progress toward personalized stem cell therapy for Parkinson's disease
Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea
Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now un
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of p
Data demonstrate 1-year survival of stem cell-derived neural progenitor cells in patients
New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable
New treatment helps achieve a healthier BMI in people with weight dysregulation after brai
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers h
A healthy diet during pregnancy associated with lower exposure to some—but not all—chemica
A healthy diet during pregnancy associated with lower exposure to some—but not all—chemica
Following dietary guidelines during pregnancy may reduce exposure to many—but not all—environmental chemicals from food and everyday products, according to a new study of nearly 1,500 pregnant participants. The study, "Dietary guidelines adherence and pregnancy exposure to 10 cla
A call for greater focus on social factors that shape health
A call for greater focus on social factors that shape health
The American College of Sports Medicine (ACSM) has published a new call to action statement urging the sports medicine community to intentionally incorporate social determinants of health (SDoH) into research, clinical care, and administrative and organizational decision-making t
Geriatric patients can independently manage appropriately-designed digital nutrition apps,
In an era where digital health applications are booming, older adults, particularly those facing the physical and psychological toll of post-acute rehabilitation, are frequently left out of the equation because of assumptions about low-tech literacy. However, a prospective pilot
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The
Foto: Shantanu Kumar / Pexels
The importance of human review in AI-driven physicians' documentation
Artificial intelligence in clinical settings is becoming more common. AI speech-to-text had a moment in the spotlight on the medical drama series "The Pitt" earlier this year. "Studies show that you can spend 80% less time charting," says character Baran Al-Hashimi, a doctor show